Are your healthcare facilities grappling with the challenges of overcrowded Emergency Departments (EDs), overburdened care providers, and limited patient access to timely care? These issues impact all stakeholders: patients struggle to access appropriate care, hospitals face heightened operational demands, and healthcare systems incur substantial costs due to non-urgent ED visits.
This session will showcase the results of a study that was conducted by Analysis Group, one of the largest international economic consulting firms. The study evaluated the financial impacts of a Healthcare Orchestration Platform, focusing on direct cost reductions associated with ER visits from a health system perspective.
You will gain an understanding of how a healthcare authority, in collaboration with Petal, a leading digital company, successfully streamlined a series of processes aimed at reducing ED overcrowding. This session will highlight three strategic processes: 1) improving care access for unattached patients, 2) ensuring timely appointments for urgent cases, and 3) redirecting non-urgent visits away from EDs. These have collectively reduced over 800 ED visits per day – alleviating strain on hospitals, improving patient flow, and generating annual financial benefits of $73.8M.
Discover how a connected system that centralizes data from nearly 20 IT systems— including provincial authentication systems, EMRs/EHRs, and booking portals—can successfully optimize access to primary care and ensure patients receive appropriate care more efficiently.
This session will offer a unique opportunity for healthcare leaders to explore how strategic initiatives combined with innovative technology and intelligent processes can reshape care delivery and set new standards for sustainable, patient-centred healthcare.
Presented by
Marie-Hélène Lafeuille, Vice President, Analysis Group, Petal Health
Marie-Hélène Lafeuille specializes in the application of biostatistics and economics to health economics and outcomes research. She brings extensive experience in analyzing retrospective databases, including medical claims, electronic health records, and clinical trial data, as well as in the design of chart review studies. Her expertise also extends to economic modeling, such as cost-effectiveness and budget impact models, as well as systematic literature reviews, including meta-analyses.
Her research covers diverse areas, including clinical efficacy, safety profile, treatment patterns, direct and indirect healthcare resource utilization and costs, and cost-effectiveness across various therapeutic areas such as oncology, hematology, dermatology, neurology, infectious diseases, endocrinology, cardiology, and respiratory. Her work includes coauthoring more than 100 research papers, published in numerous peer-reviewed journal, and presented at a wide range of scientific conferences.
Elliott Desilets, Business Development Director, Petal Health
Elliot has over ten years of experience working with healthcare systems across Canada and the United States. He is currently the Director of Business Development, Public Sector (Western and Atlantic Canada) for Petal Health where he supports and leads engagements with stakeholders across Canada’s healthcare system related to improving access to care. Elliot also serves as a member of the Board of Directors for the HIMSS Prairies Chapter and is an active member of Digital Health Canada.